nafamostat has been researched along with galactosyl-(1-3)galactose in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borgen, MS; Fiane, AE; Haraldsen, G; Lea, T; Michaelsen, TE; Mollnes, TE; Saethre, M; Thorsby, E | 1 |
1 other study(ies) available for nafamostat and galactosyl-(1-3)galactose
Article | Year |
---|---|
Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation.
Topics: Animals; Aorta; Benzamidines; Cell Culture Techniques; Complement Activation; Complement Inactivating Agents; Disaccharides; E-Selectin; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Graft Rejection; Guanidines; Guinea Pigs; Humans; Immunoglobulin G; Primates; Staphylococcal Protein A; Swine; Transplantation, Heterologous | 2006 |